OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Adenovirus Death Protein – a small membrane protein controls cell lysis and disease
Fanny Georgi, Urs F. Greber
FEBS Letters (2020) Vol. 594, Iss. 12, pp. 1861-1878
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

The endoplasmic reticulum unfolded protein response – homeostasis, cell death and evolution in virus infections
Vibhu Prasad, Urs F. Greber
FEMS Microbiology Reviews (2021) Vol. 45, Iss. 5
Open Access | Times Cited: 72

Emerging antiviral therapeutics for human adenovirus infection: Recent developments and novel strategies
Mackenzie J. Dodge, Katelyn M. MacNeil, Tanner M. Tessier, et al.
Antiviral Research (2021) Vol. 188, pp. 105034-105034
Open Access | Times Cited: 57

Frontiers and future of immunotherapy for pancreatic cancer: from molecular mechanisms to clinical application
Rui Zheng, Xiaobin Liu, Yufu Zhang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 7

Advances of Recombinant Adenoviral Vectors in Preclinical and Clinical Applications
Luca Scarsella, Eric Ehrke‐Schulz, Michael Paulussen, et al.
Viruses (2024) Vol. 16, Iss. 3, pp. 377-377
Open Access | Times Cited: 6

Adenoviruses – Infection, pathogenesis and therapy
Urs F. Greber
FEBS Letters (2020) Vol. 594, Iss. 12, pp. 1818-1827
Open Access | Times Cited: 43

Functional roles of the membrane-associated AAV protein MAAP
Lionel Galibert, Amira Hyvönen, Reetta A. E. Eriksson, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 39

Current landscape and perspective of oncolytic viruses and their combination therapies
Yinghan Su, Changqing Su, Lun‐Xiu Qin
Translational Oncology (2022) Vol. 25, pp. 101530-101530
Open Access | Times Cited: 24

REV7: a small but mighty regulator of genome maintenance and cancer development
Lara R. Maggs, Mitch McVey
Frontiers in Oncology (2025) Vol. 14
Open Access

Adenovirus replication
Rachel L. White, Patrick Hearing
Elsevier eBooks (2025), pp. 75-98
Closed Access

The Transmission of SARS-CoV-2 Infection on the Ocular Surface and Prevention Strategies
Koji Kitazawa, Stefanie Deinhardt‐Emmer, Takenori Inomata, et al.
Cells (2021) Vol. 10, Iss. 4, pp. 796-796
Open Access | Times Cited: 31

Microscopy deep learning predicts virus infections and reveals mechanics of lytic-infected cells
Vardan Andriasyan, Artur Yakimovich, Anthony Petkidis, et al.
iScience (2021) Vol. 24, Iss. 6, pp. 102543-102543
Open Access | Times Cited: 27

Triple-serotype chimeric oncolytic adenovirus exerts multiple synergistic mechanisms against solid tumors
Yinghan Su, Jiang Li, Weidan Ji, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 5, pp. e004691-e004691
Open Access | Times Cited: 14

Nuclear entry and egress of parvoviruses
Salla Mattola, Vesa Aho, Luisa Bustamante-Jaramillo, et al.
Molecular Microbiology (2022) Vol. 118, Iss. 4, pp. 295-308
Open Access | Times Cited: 14

The FDA-Approved Drug Nelfinavir Inhibits Lytic Cell-Free but Not Cell-Associated Nonlytic Transmission of Human Adenovirus
Fanny Georgi, Vardan Andriasyan, Robert Witte, et al.
Antimicrobial Agents and Chemotherapy (2020) Vol. 64, Iss. 9
Open Access | Times Cited: 22

Viral Infection and Antiviral Treatments in Ocular Pathologies
Francesco Petrillo, Arianna Petrillo, Francesca Paola Sasso, et al.
Microorganisms (2022) Vol. 10, Iss. 11, pp. 2224-2224
Open Access | Times Cited: 9

Fragile X-Related Protein FXR1 Controls Human Adenovirus Capsid mRNA Metabolism
Zamaneh Hajikhezri, Yanina Kaira, Erik Schubert, et al.
Journal of Virology (2023) Vol. 97, Iss. 2
Open Access | Times Cited: 5

Evaluation of Human Mesenchymal Stromal Cells as Carriers for the Delivery of Oncolytic HAdV-5 to Head and Neck Squamous Cell Carcinomas
Robin Nilson, Lea Krutzke, Frederik Wienen, et al.
Viruses (2023) Vol. 15, Iss. 1, pp. 218-218
Open Access | Times Cited: 3

Oncolytic Virus-Induced Autophagy in Glioblastoma
Мargarita Kamynina, Salome Tskhovrebova, Jawad Fares, et al.
Cancers (2021) Vol. 13, Iss. 14, pp. 3482-3482
Open Access | Times Cited: 8

Locked and loaded: engineering and arming oncolytic adenoviruses to enhance anti-tumor immune responses
Shao‐Chia Lu, Michael A. Barry
Expert Opinion on Biological Therapy (2022) Vol. 22, Iss. 11, pp. 1359-1378
Open Access | Times Cited: 4

Human adenoviruses: A suspect behind the outbreak of acute hepatitis in children amid the COVID-19 pandemic
Hongyun Wang, Shimin Yang, Jiejie Liu, et al.
Cell Insight (2022) Vol. 1, Iss. 4, pp. 100043-100043
Open Access | Times Cited: 4

Stepwise virus assembly in the cell nucleus revealed by spatiotemporal click chemistry of DNA replication
Alfonso Gómez-González, Patricia Burkhardt, Michael Bauer, et al.
Science Advances (2024) Vol. 10, Iss. 43
Open Access

Development and Characterization of an Oncolytic Human Adenovirus-Based Vector Co-Expressing the Adenovirus Death Protein and p14 Fusion-Associated Small Transmembrane Fusogenic Protein
Kathy L. Poulin, Ryan G. Clarkin, Joshua Del Papa, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 22, pp. 12451-12451
Open Access

CURRENT PERSPECTIVES OF VIROTHERAPY AS A CANCER TREATMENT STRATEGY
L. F. Vlasova
Russian Journal of Infection and Immunity (2024) Vol. 14, Iss. 6, pp. 1063-1069
Open Access

Page 1 - Next Page

Scroll to top